Screen Shot 2020-07-21 at 4.01.17 PM.png

15 new startups that have received funding from Antler

Global startup generator and early-stage VC firm Antler has announced the 15 new companies that have graduated and received investment from its fourth Singapore programme.

Malaysian companies develop Covid-19 rapid test kits

Homegrown technology company Biogenes Technologies Sdn Bhd is developing an aptamer-based biosensor against the novel coronavirus that can accurately deliver test results in under one minute. 

BH covid 19.webp

COVID-19: Syarikat naungan AIM hasil vaksin, kit ujian

KUALA LUMPUR: Lima syarikat kini dalam pelbagai fasa bagi mengetengahkan produk perubatan untuk pengesanan virus dan klinikal, selain merintis usaha penyelidikan vaksin COVID-19.

 

Syarikat itu merangkumi Twin Catalyst Sdn Bhd, TTMC Sdn Bhd, Medical Innovation Ventures Sdn Bhd (Mediven), Biogenes Technologies Sdn Bhd dan IN3Bio.

COVIDSENS product system.jpg

Malaysian company develops Covid-19 rapid test kits that can deliver results under 20 minutes

KUALA LUMPUR, Feb 26 — A homegrown diagnostic solution start-up has developed a digital rapid Covid-19 test kit — dubbed APTSENS — that can upload test results in real-time with geo-location data to cloud servers via a mobile app.

Kit ujian Covid hanya dalam masa 20 minit

KUALA LUMPUR, 26 Februari – Permulaan penyelesaian diagnostik tempatan telah mengembangkan kit ujian Covid-19 secara cepat dan digital – yang diberi nama APTSENS – yang dapat memuat naik hasil ujian dalam masa nyata dengan data lokasi geografi ke pelayan awan (cloud server) melalui aplikasi mudah alih.

malaysia.kom.jpg

马来西亚公司开发Covid-19快速测试套件,可在20分钟内提供结果

吉隆坡,2月26日-一家本土诊断解决方案初创公司开发了数字快速Covid-19测试套件(称为APTSENS),该套件可以通过移动应用程序将地理位置数据实时地将测试结果上传到云服务器。

IMG_2336.jpg

M’sian made aptamer-based biosensor makes its mark

A locally developed aptamer-based biosensor is set to change the way we monitor human body, pathogens, food and environmental contaminants.

AIM Ambil Pendekatan Inovatif Perangi Covid-19 

Agensi Inovasi Malaysia (AIM) melalui empat syarikat Program Berimpak Tinggi 2 (HIP2) di bawah PlaTCOM Ventures Sdn Bhd dan sebuah syarikat pelaburan mengambil pendekatan inovatif untuk memerangi koronavirus (Covid-19) dengan menghasilkan produk perubatan dan klinikal selain memulakan penyelidikan vaksin.

Syarikat tersebut ialah Twin Catalyst Sdn Bhd, TTMC Sdn Bhd, Medical Innovation Ventures Sdn Bhd (Mediven), Biogenes Technologies Sdn Bhd dan IN3Bio.

Group photo.HEIC

15 Startups graduated from Antler's fourth Singapore cohort and COVID-19 Initiative

Bio Genes: A startup that produces aptamer-based (synthetic antibody) diagnostics products via an in-house proprietary technology platform.

biogenesis petri dish.jpg

Biogenes signs exclusive licensing agreement with IUKL

BANGI: Bioegenes Technologies Sdn Bhd (Biogenes), a Malaysian-based company in the field of molecular diagnostics and genomics has signed a licensing agreement with Infrastructure University Kuala Lumpur (IUKL) to commercialise Aptamer technology.

IMG_4003.jpg

Antibodies, aptamer & a kinder approach

The very nature of our technology helps you go outside and try it in the field. 

Pic 3.jpg

Collaborating genomic tech for precision breeding

Monash University Malaysia and Biogenes Technologies Sdn Bhd signed a Memorandum of Agreement (MoA) on collaborative research to develop genomic technologies.